TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for aggressive breast cancer falls short in early trial
Disease control TerminatedThis study tested a two-drug combination (nab-paclitaxel and alpelisib) given before surgery to people with a hard-to-treat type of breast cancer called triple-negative breast cancer that also had specific genetic changes (PIK3CA or PTEN). The goal was to see if the drugs could s…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
New hope for chemo-resistant breast cancer? trial tests targeted pill
Disease control TerminatedThis study tested a drug called abemaciclib in people with triple negative breast cancer that did not shrink with standard chemotherapy. The goal was to see if the drug could change the immune environment inside the tumor, making it more responsive. The trial was stopped early, b…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC